Aileron Therapeutics, Inc. ALRN
Trading inactive
| Déclarant | Citoyenneté ou lieu d'organisation | Pouvoir de vote unique | Pouvoir de vote partagé | Pouvoir de disposition unique | Pouvoir de disposition partagé | Montant en propriété effective | Pourcentage détenu | Date d'achat |
|---|---|---|---|---|---|---|---|---|
| The University of Texas/Texas A&M Investment Management Company | TX | 0 | 1812627 | 0 | 1812627 | 1812627 | 6.2 % | 05/03/2024 |
| BIOS EQUITY PARTNERS III, LP | TEXAS, UNITED STATES | 0 | 542256 | 0 | 0 | 542256 | 9.99 % | 13/11/2023 |
| BIOS CAPITAL MANAGEMENT, LP | TEXAS, UNITED STATES | 0 | 521016 | 0 | 0 | 521016 | 9.99 % | 13/11/2023 |
| BIOS FUND II NT, LP | DELAWARE, UNITED STATES | 0 | 144365 | 0 | 0 | 144365 | 2.87 % | 13/11/2023 |
| BIOS FUND III QP, LP | DELAWARE, UNITED STATES | 0 | 542256 | 0 | 0 | 542256 | 9.99 % | 13/11/2023 |
| BIOS LTI SPV II, LP | DELAWARE, UNITED STATES | 0 | 540023 | 0 | 0 | 540023 | 9.99 % | 13/11/2023 |
| BIOS FUND I, LP | DELAWARE, UNITED STATES | 0 | 539293 | 0 | 0 | 539293 | 9.99 % | 13/11/2023 |
| BIOS FUND II, LP | DELAWARE, UNITED STATES | 0 | 332278 | 0 | 0 | 332278 | 6.37 % | 13/11/2023 |
| BIOS LTI CO-INVEST III QP, LP | DELAWARE, UNITED STATES | 0 | 536029 | 0 | 0 | 536029 | 9.99 % | 13/11/2023 |
| AARON GLEN LOUIS FLETCHER | UNITED STATES | 10540 | 509306 | 10540 | 0 | 519846 | 9.99 % | 13/11/2023 |
| LESLIE WAYNE KREIS, JR. | UNITED STATES | 1819 | 518995 | 1819 | 0 | 520814 | 9.99 % | 13/11/2023 |
| BIOS FUND II QP, LP | DELAWARE, UNITED STATES | 0 | 540370 | 0 | 0 | 540370 | 9.99 % | 13/11/2023 |
| BIOS FUND I QP, LP | DELAWARE, UNITED STATES | 0 | 540039 | 0 | 0 | 540039 | 9.99 % | 13/11/2023 |
| BIOS EQUITY PARTNERS, LP | TEXAS, UNITED STATES | 0 | 536033 | 0 | 0 | 536033 | 9.99 % | 13/11/2023 |
| BIOS LTI CO-INVEST III, LP | DELAWARE, UNITED STATES | 0 | 536182 | 0 | 0 | 536182 | 9.99 % | 13/11/2023 |
| CAVU ADVISORS, LLC | TEXAS, UNITED STATES | 0 | 521016 | 0 | 0 | 521016 | 9.99 % | 13/11/2023 |
| CAVU MANAGEMENT, LP | TEXAS, UNITED STATES | 0 | 521016 | 0 | 0 | 521016 | 9.99 % | 13/11/2023 |
| BIOS ADVISORS GP, LLC | TEXAS, UNITED STATES | 0 | 521016 | 0 | 0 | 521016 | 9.99 % | 13/11/2023 |
| BIOS CLINICAL OPPORTUNITY FUND, LP | DELAWARE, UNITED STATES | 0 | 542256 | 0 | 0 | 542256 | 9.99 % | 13/11/2023 |
| BIOS FUND III, LP | DELAWARE, UNITED STATES | 0 | 178500 | 0 | 0 | 178500 | 3.52 % | 13/11/2023 |
| BIOS EQUITY PARTNERS II, LP | TEXAS, UNITED STATES | 0 | 527239 | 0 | 0 | 527239 | 9.99 % | 13/11/2023 |
| BIOS FUND III NT, LP | DELAWARE, UNITED STATES | 0 | 187500 | 0 | 0 | 187500 | 3.7 % | 13/11/2023 |
| BIOS EQUITY COF, LP | TEXAS, UNITED STATES | 0 | 542256 | 0 | 0 | 542256 | 9.99 % | 13/11/2023 |
| Scott B. Kapnick | 7592222 | 0 | 7592222 | 0 | 7592222 | 8.4 % | 14/02/2022 | |
| BVF GP HOLDINGS LLC | Delaware | 0 | 0 | 0 | 4827023 | 4827023 | 5.8 % | 19/01/2021 |
| BVF Partners L.P. | Delaware | 0 | 0 | 0 | 5265555 | 5265555 | 6.3 % | 19/01/2021 |
| BVF I GP LLC | Delaware | 0 | 0 | 0 | 2779536 | 2779536 | 3.3 % | 19/01/2021 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 0 | 0 | 2047487 | 2047487 | 2.5 % | 19/01/2021 |
| BVF II GP LLC | Delaware | 0 | 0 | 0 | 2047487 | 2047487 | 2.5 % | 19/01/2021 |
| Biotechnology Value Trading Fund OS LP | Delaware | 0 | 0 | 0 | 335997 | 335997 | 1 % | 19/01/2021 |
| BVF Partners OS Ltd. | Delaware | 0 | 0 | 0 | 335997 | 335997 | 1 % | 19/01/2021 |
| BVF Inc. | Delaware | 0 | 0 | 0 | 5265555 | 5265555 | 6.3 % | 19/01/2021 |
| Mark N. Lampert | Delaware | 0 | 0 | 0 | 5265555 | 5265555 | 6.3 % | 19/01/2021 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 0 | 0 | 2779536 | 2779536 | 3.3 % | 19/01/2021 |
| Scott B. Kapnick | United State of America | 3377222 | 0 | 3377222 | 0 | 3377222 | 8.8 % | 08/06/2020 |
| Novartis AG | 0 | 1199904 | 0 | 11 | 1199904 | 4.31 % | 16/04/2020 | |
| Novartis Bioventures Ltd. | 0 | 1199904 | 0 | 11 | 1199904 | 4.31 % | 16/04/2020 | |
| Novartis AG | 0 | 1572285 | 0 | 11 | 1572285 | 5.65 % | 13/04/2020 | |
| Novartis Bioventures Ltd. | 0 | 1572285 | 0 | 11 | 1572285 | 5.65 % | 13/04/2020 | |
| Novartis Bioventures Ltd. | 0 | 1882119 | 0 | 11 | 1882119 | 6.77 % | 18/03/2020 | |
| Novartis AG | 0 | 1882119 | 0 | 11 | 1882119 | 6.77 % | 18/03/2020 | |
| Armistice Capital, LLC | 0 | 1460620 | 0 | 1460620 | 1460620 | 4.99 % | 14/02/2020 | |
| Steven Boyd | 0 | 1460620 | 0 | 1460620 | 1460620 | 4.99 % | 14/02/2020 | |
| Armistice Capital Master Fund Ltd. | 0 | 1460620 | 0 | 1460620 | 1460620 | 4.99 % | 14/02/2020 | |
| Lilly Ventures Fund I, LLC | Delaware | 0 | 1094987 | 0 | 10 | 1094987 | 3.9 % | 13/08/2019 |
| S. Edward Torres | Delaware | 0 | 1094987 | 0 | 10 | 1094987 | 3.9 % | 13/08/2019 |
| Armen B. Shanafelt, Ph.D. | Delaware | 0 | 1094987 | 0 | 10 | 1094987 | 3.9 % | 13/08/2019 |
| LV Management Group, LLC | Delaware | 0 | 1094987 | 0 | 10 | 1094987 | 3.9 % | 13/08/2019 |
| Steven E. Hall, Ph.D. | Delaware | 0 | 1094987 | 0 | 10 | 1094987 | 3.9 % | 13/08/2019 |
| Armistice Capital Master Fund Ltd. | Delaware | 0 | 2137089 | 0 | 2137089 | 2137089 | 8 % | 08/04/2019 |
| Armistice Capital, LLC | Delaware | 0 | 2137089 | 0 | 2137089 | 2137089 | 8 % | 08/04/2019 |
| Steven Boyd | Delaware | 0 | 2137089 | 0 | 2137089 | 2137089 | 8 % | 08/04/2019 |
| Seth L. Harrison | Delaware | 0 | 2305383 | 0 | 2305383 | 2305383 | 15.7 % | 09/02/2018 |
| Apple Tree Partners II, L.P. | Delaware | 0 | 2305383 | 0 | 2305383 | 2305383 | 15.7 % | 09/02/2018 |
| Apple Tree Ventures II, L.P. | Delaware | 0 | 2305383 | 0 | 2305383 | 2305383 | 15.7 % | 09/02/2018 |
| Apple Tree Partners II – Annex, L.P. | Delaware | 0 | 2305383 | 0 | 2305383 | 2305383 | 15.7 % | 09/02/2018 |
| Apple Tree Ventures II - Annex, LLC | Delaware | 0 | 2305383 | 0 | 2305383 | 2305383 | 15.7 % | 09/02/2018 |
| LV Management Group, LLC | Delaware | 0 | 1094987 | 0 | 10 | 1094987 | 7.4 % | 17/07/2017 |
| S. Edward Torres | United States | 0 | 1094987 | 0 | 10 | 1094987 | 7.4 % | 17/07/2017 |
| Armen B. Shanafelt, Ph.D. | United States | 0 | 1094987 | 0 | 10 | 1094987 | 7.4 % | 17/07/2017 |
| Lilly Ventures Fund I, LLC | Delaware | 0 | 1094987 | 0 | 10 | 1094987 | 7.4 % | 17/07/2017 |
| Steven E. Hall, Ph.D. | United States | 0 | 1094987 | 0 | 10 | 1094987 | 7.4 % | 17/07/2017 |